Shaharyar Khan, PhD, Chief Scientific Officer Number Of Employees: ~27 Stage: Private, Series B2 Financial Snapshot: Has raised $224M total across funding rounds, including a $132M Series B Notable Investors: RA Capital Management
A randomized clinical trial reported that vitamin D supplementation in men was associated with improved reproductive outcomes, including live birth in couples, though effects on semen parameters are not consistent across all studies
GHK-Cu
A PubMed-listed study explored BPC-157 in tendon fibroblast and tendon explant models
Boasting domestic manufacturing, ex-Novo Nordisk leadership and a market hungry for cheaper GLP-1s, Toronto start-up Vimy Pharma says it plans to produce a Canadian-made generic of Ozempic (semaglutide) as protections on the blockbuster diabetes/obesity drug unwind in Canada in early 2026
Choosing the Right B12 Supplement for Your Needs When choosing a B12 supplement, consider your unique needs